Effect of a Chatbot on Nursing Students' Self-Efficacy in Pediatric Medication Administration (CHATPED)
Effect of a Chatbot-Supported Clinical Training on Nursing Students' Self-Efficacy in Pediatric Medication Administration: A Randomized Controlled Trial
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
This was a two-group, parallel, pre-test-post-test randomized controlled trial evaluating the effect of a chatbot-supported clinical training on nursing students' self-efficacy in pediatric medication administration. The trial was reported in accordance with the CONSORT statement.
All eligible third-year nursing students entering the pediatric clinical placement were invited (complete enumeration), and 106 students who consented were enrolled. Participants were allocated to an experimental group (n=53) and a control group (n=53) using fixed block randomization (block size = 6).
Both groups received the routine curriculum. The experimental group additionally used a web-based chatbot before and during the placement. The chatbot contained two modules: a dose calculator (computing required drug amount and volume from the child's weight, prescribed dose, and drug concentration) and a question-answer assistant. The chatbot's content was drawn solely from a validated pediatric nursing reference textbook rather than free AI-generated responses. The control group accessed standard clinical references only. After the study, the control group was also offered access to the chatbot.
Data were analyzed using independent- and paired-samples t-tests and analysis of covariance (ANCOVA) with the pre-test score as a covariate.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Istanbul, Tyrkia (Türkiye)
- Üsküdar Univercity
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Third-year nursing student
- Entering the pediatric (child health and diseases) clinical placement for the first time
- Owning a smartphone or computer
- Providing voluntary informed consent to participate
Exclusion Criteria:
- Previous completion of a pediatric clinical placement
- Prior participation in a similar educational intervention
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Experimental group
Participants received the routine curriculum and additionally used a web-based chatbot (a dose calculator and a book-based question-answer assistant) before and during the pediatric clinical placement.
|
A web-based chatbot accessible via mobile and desktop browsers, containing two modules: an advanced dose calculator that computes required drug amount and volume from the child's weight, prescribed dose, and drug concentration; and a question-answer assistant that responds to pediatric medication questions using content drawn solely from a validated pediatric nursing reference textbook.
|
|
Ingen inngripen: Control group
Participants received the routine curriculum and accessed standard clinical references only, without the chatbot.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-efficacy in pediatric medication administration
Tidsramme: Baseline (before the pediatric clinical placement) and post-intervention (after completion of the placement, approximately at the end of the clinical rotation). Baseline (Day 1) and post-intervention (Week 8)
|
Self-efficacy measured with the Medication Administration Self-Efficacy Scale in Children for Nursing Students (MASSCNS), a 16-item, 5-point Likert scale with total scores ranging from 16 to 80. Higher scores indicate greater self-efficacy.
Change from pre-test to post-test was compared between groups.
|
Baseline (before the pediatric clinical placement) and post-intervention (after completion of the placement, approximately at the end of the clinical rotation). Baseline (Day 1) and post-intervention (Week 8)
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- CHATBOT-PED-USKUDAR
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .